Significant M&A Agreements Are On The Horizon For 2023
According to EY's 2023 M&A Firepower report, the life sciences sector has record levels of deal-making Firepower, which measures a company's ability to undertake...
Cancer Treatment Rates In NHS Hit An All-Time High In 2022
The NHS has released encouraging statistics regarding cancer rates in the UK to kick off the new year. Over the past year, more patients...
Quality Assurance Advances In Pharmaceutical Manufacturing
The needs of manufacturing facilities, tools, and procedures must be suitable for this new environment as the focus of new drug research shifts toward...
India Keen To Establish National Database On Dosage Forms
In an effort to better inform and empower consumers, the Indian government has announced plans to create a comprehensive database on every medicinal composition...
Pharma Alliance Worth $5 Billion In Bispecific Antibodies
Ivonescimab (PD-1/VEGF, AK112), a ground-breaking bispecific antibody, will be out-licensed by Biopharma Akeso Inc. to Summit Therapeutics Inc. for use in research and development...
Etihad Cargo Joins Forces With A New Cold Storage Facility
A new cold chain facility being built by Etihad Cargo, Etihad Airport Services, and Abu Dhabi Airports will more than increase the carrier's pharmaceutical...
India Seeks Better Pharma Market Access In The UK: Official
As a part of the proposed free trade deal with Britain, India is looking at expanding access to markets for its pharmaceutical products in...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...